Incident-to Billing Case Scenario A 51-year-old female patient returns for a follow-up visit with a physician assistant (PA) for unilateral primary osteoarthritis of her right knee. She had an intraarticular corticosteroid injection of her right knee six weeks prior to her visit. She reports significant improvement in her knee pain and stiffness, and states the…
Rheumatology Coding Corner Answer: Knee Osteoarthritis
Diagnoses: ICD-9 715.16, 528.02, E943.8 ICD-10 M17.11, K12.32, T39.395A This was an established patient visit with a new diagnosis. Because the PA sought out the physician to address the new problem and document the assessment and treatment, the visit can still be billed as incident-to. Note: The physician initiated the plan of care for treatment…
Diagnostic Imaging in Patient with Elbow Pain: Findings
View the question. Transverse (see Figure 1) and longitudinal (see Figure 2) ultrasound images show an anechoic collection (asterisks), which surrounds the distal biceps tendon (b). The collection is compressible (not shown here). The biceps tendon is heterogeneous in echo texture, with fiber dropouts and an irregular border (in the transverse view). The elbow joint…
Former Foundation President Reflects on 30 Years of Research & Training
Q&A with inaugural president Arthur Weaver, MD, MS, as the Foundation marks its 30th anniversary
In Memoriam: Remembering Rheumatologists Stephen M. Krane, MD, Nathan J. Zvaifler, MD, Franc Alexander ‘Andy’ Barada Jr., MD
Professional rheumatology community mourns loss of physicians who made great contributions to specialty
Rheumatology Research Foundation Receives $1 Million Donation
Norman B. Gaylis, MD, provides funds to benefit physician-driven medical research; establish ongoing research award for practicing rheumatologists
Value of Patient Care Services in Rheumatology Gets Boost
By developing guidelines, quality measures, data on patient outcomes, the ACR helps rheumatologists translate the value of their work to the world
Prior Authorization Requests Delay or Prevent Delivery of Needed Meds
Rheumatologist denounces common practice as a time-draining impediment to patient care
The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market
With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases
Rheumatologists on the Move
Awards, appointments and announcements in the world of rheumatology
- « Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 103
- Next Page »